The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

An Amgen obesity drug helped participants lose a substantial amount of weight, but questions about how competitive it could ...

MAHA supporters share a disturbing sense that the health care system and its regulators don’t have people’s best interests at heart ...

Will the Novo-Catalent merger be challenged under the new Trump administration? A former FTC policy director thinks so.

What’s more, the rise of technology in medicine, while beneficial in many ways, has further reduced the use of empathic touch ...

A cancer treatment from Roche failed to improve survival in a major lung cancer study, a result that will stoke doubts about ...

Former HHS Secretary Tom Price writes that the new Trump administration should update immigration laws to help the U.S.

Sarepta Therapeutics said Tuesday that it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of ...

The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These ...

Alector Therapeutics, working with AbbVie, was testing whether modulating immune cells in brain would slow Alzheimer's ...

The Cassava Sciences story ended Monday exactly as many knew it would — with the company’s experimental drug for Alzheimer’s ...

Late Friday evening, President-elect Donald Trump announced a slew of intended nominations for his administration, including ...